Remzi Feza H, Fazio Victor W, Delaney Conor P, Preen Miriam, Ormsby Adrian, Bast Jane, O'Riordain Michael G, Strong Scott A, Church James M, Petras Robert E, Gramlich Terry, Lavery Ian C
Department of Colorectal Surgery, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
Dis Colon Rectum. 2003 Jan;46(1):6-13. doi: 10.1007/s10350-004-6488-2.
Stapling of the ileal pouch-anal anastomosis with preservation of the anal transitional zone remains controversial because of concerns about the potential risk of dysplasia and cancer. The natural history and optimal treatment of anal transitional zone dysplasia ten or more years after surgery are unknown. This study establishes the risk of dysplasia in the anal transitional zone and the outcome of a conservative management policy for anal transitional zone dysplasia, with a minimum of ten years' follow-up after ileal pouch-anal anastomosis.
A total of 289 patients undergoing anal transitional zone-sparing stapled ileal pouch-anal anastomosis for inflammatory bowel disease between 1986 and 1990 were studied. Patients undergoing anal transitional zone-sparing ileal pouch-anal anastomosis who were studied with serial anal transitional zone biopsies for at least ten years postoperatively were included (n = 178). Median follow-up was 130 (range, 120-157) months.
Anal transitional zone dysplasia developed in 8 patients 4 to 123 (median, 9) months after surgery. There was no association with gender, age, preoperative disease duration, or extent of colitis, but the risk of anal transitional zone dysplasia was significantly associated with cancer or dysplasia as a preoperative diagnosis or in the proctocolectomy specimen. Dysplasia was high grade in two patients and low grade in six. Two patients with low-grade dysplasia on two or more occasions after detection of low-grade dysplasia underwent completion mucosectomy and perineal pouch advancement with neo-ileal pouch-anal anastomosis. One patient with high-grade dysplasia on two occasions was to undergo completion mucosectomy, but this was not technically feasible. Partial mucosectomy with vigorous anal transitional zone biopsy was performed with close postoperative surveillance. Biopsies were negative for dysplasia. The second recently diagnosed patient with high-grade dysplasia underwent examination under anesthesia with negative anal transitional zone biopsies and will be kept under close surveillance. No cancer in the anal transitional zone was found during the study period. The 4 other patients with low-grade dysplasia on 1 or 2 occasions were treated expectantly and have been dysplasia free for a median of 119 (range, 103-133) months.
Anal transitional zone dysplasia after stapled ileal pouch-anal anastomosis is infrequent and is usually self-limiting. Anal transitional zone preservation did not lead to the development of cancer in the anal transitional zone with a minimum of ten years of follow-up. Long-term surveillance is recommended to monitor dysplasia. If repeat biopsy confirms persistent dysplasia, mucosectomy with perineal pouch advancement and neo-ileal pouch-anal anastomosis is recommended.
由于担心发育异常和癌症的潜在风险,保留肛管移行区进行回肠储袋肛管吻合术一直存在争议。术后十年或更长时间肛管移行区发育异常的自然病程和最佳治疗方法尚不清楚。本研究确定了肛管移行区发育异常的风险以及针对肛管移行区发育异常的保守治疗策略的结果,在回肠储袋肛管吻合术后至少随访十年。
对1986年至1990年间因炎症性肠病接受保留肛管移行区的吻合器回肠储袋肛管吻合术的289例患者进行了研究。纳入了接受保留肛管移行区的回肠储袋肛管吻合术且术后至少十年接受系列肛管移行区活检的患者(n = 178)。中位随访时间为130(范围120 - 157)个月。
8例患者在术后4至123(中位时间9)个月出现肛管移行区发育异常。与性别、年龄、术前疾病持续时间或结肠炎范围无关,但肛管移行区发育异常的风险与术前诊断或直肠结肠切除标本中的癌症或发育异常显著相关。2例患者为高级别发育异常,6例为低级别发育异常。2例低级别发育异常患者在检测到低级别发育异常后多次出现低级别发育异常,接受了完整黏膜切除术及会阴储袋推进术并进行了新的回肠储袋肛管吻合术。1例高级别发育异常患者两次出现高级别发育异常,原计划进行完整黏膜切除术,但技术上不可行。进行了部分黏膜切除术并对肛管移行区进行了积极活检,术后密切监测。活检未发现发育异常。第二位最近诊断为高级别发育异常的患者在麻醉下检查,肛管移行区活检为阴性,将继续密切监测。研究期间未发现肛管移行区癌症。另外4例低级别发育异常患者出现1或2次低级别发育异常,采取观察等待治疗,目前已无发育异常,中位时间为119(范围103 - 133)个月。
吻合器回肠储袋肛管吻合术后肛管移行区发育异常并不常见,通常为自限性。保留肛管移行区在至少十年的随访中未导致肛管移行区癌症的发生。建议进行长期监测以监测发育异常。如果重复活检证实持续存在发育异常,建议进行黏膜切除术及会阴储袋推进术并进行新的回肠储袋肛管吻合术。